by John A. Jenkins | Jul 17, 2025 | FDA, FOIA, Hedge Funds, Stock Market
FOIAengine: How a Proxy Requester Masks Its Identity On April 14, 2021, online forums where retail investors and short sellers exchange research, rumors, and trading strategies were buzzing. On Reddit and Twitter, meme stock traders were watching for the next big...
by John A. Jenkins | Jul 9, 2025 | FDA, FOIA, Hedge Funds, Stock Market
FOIAengine: Decoding How a Hedge Fund Tracks FDA Requests ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and high-profile...
by Randy E. Miller | May 28, 2025 | FDA, FOIA, Hedge Funds, Medical Devices, Stock Market
FOIAengine: Multiple Hedge Funds Seeking Inspection Reports Leading medical device manufacturer Insulet Corporation’s stock price (NASDAQ: PODD) is on a roll. But that hasn’t stopped financial firms from monitoring the company’s Food and Drug Administration plant...
by John A. Jenkins | May 8, 2025 | FDA, FOIA, FTC, News Media, SEC
The Latest Requests Logged in FOIAengine Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s regulatory nominees are among those in newly available Freedom of Information Act requests filed by media organizations with the...
by Randy E. Miller | Apr 23, 2025 | FDA, FOIA, Hedge Funds, Pharmaceuticals
FOIAengine: Questions Seek Adverse Reports about Carvykti According to a new PoliScio Analytics analysis of early 2025 Freedom of Information Act requests, investment firm Point72 has launched a significant FOIA-driven investigation into Johnson &...
by John A. Jenkins | Apr 9, 2025 | FDA, FOIA, Medical Devices, Pharmaceuticals
FOIAengine: Revolving Door Hits Pfizer on the Way Out The revolving door between the Food and Drug Administration and the pharmaceutical industry took another fast spin when Pfizer announced that Patrizia Cavazzoni would be returning to the company as its chief...
